In contrast with the neuroprotective efficacy of competitive and non-competitive N-methyl-d-
aspartate (NMDA) antagonists versus NMDA neurotoxicity, reported neuroprotective effects …

Background Chronic immunosuppressive treatment with cyclosporine A (CsA) leads to
multiple side effects, including some that occur in the central nervous system (CNS). This …

Methamphetamine (METH) causes irreversible damage to brain cells leading to
neurological and psychiatric abnormalities. However, the mechanisms underlying life …

Glial-cell-line-derived neurotrophic factor (GDNF) is a potent survival factor for several types
of neurons. In the present study, we examined the protective roles of adenoviral-vector …

The incidence of methamphetamine abuse is particularly high in adolescents and is a
common problem among women of childbearing age, leading to an increasing number of …

The role of a nuclear factor κB (NF‐κB) in NMDA receptor‐mediated neuroprotection is not
known. A candidate sequence from the 5′ flanking region of exon 3 of the rat brain‐derived …

Current evidence suggests that ginsenosides inhibit methamphetamine (MA)-induced
changes in behavior, but the precise mechanisms that underlie this effect are yet to be …

Abnormal N-methyl-D-aspartate receptor (NMDAr) function has been linked to
oscillopathies, psychosis, and cognitive dysfunction in schizophrenia (SCZ). Here, we …

Excitotoxicity mediated by overactivation of N-methyl-d-aspartate receptors (NMDARs) has
been implicated in a variety of neuropathological conditions in the central nervous system …

In order to reach deeper insight into the mechanism of diethyldithiocarbamate (DDC)-
induced enhancement of MPTP toxicity in mice, MK-801, a non-competitive antagonist of …